Datopotamab deruxtecan (Dato-DXd) enhances antitumor response to PD-1/PD-L1 inhibitors in TROP2-expressing tumors in mice

Okajima, D; Yasuda, S; Suzuki, T; Kitamura, M; Yamaguchi, J; Maejima, T; Karibe, T; Toki, T; Phillips, P; Agatsuma, T

CANCER RESEARCH, 2023; 83 (7):